Combined live clostridium butyricum and bifidobacterium (Shandong Kexing Bioproducts)
酪酸梭菌二联活菌散（胶囊）（山东科兴生物制品有限公司）
Report date: 2022/09/27 17:03:20
Base Information
Drug NameCombined live clostridium butyricum and bifidobacterium (Shandong Kexing Bioproducts)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/04/12
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A